Skip to content

Stroke Volume Variation-guided Fluid Infusion in Major Liver Tumour Resection

Restrictive Versus Liberal Stroke Volume Variation-guided Fluid Infusion in Major Liver Tumour Resection: a Prospective Randomised Trial of Perioperative Quality of Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05361252
Enrollment
118
Registered
2022-05-04
Start date
2017-02-01
Completion date
2018-12-31
Last updated
2022-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fluid Management

Keywords

Stroke volume variation, Fluid therapy, Hepatectomy, Alanine aminotransferase, Estimated glomerular filtration rate

Brief summary

Studies have demonstrated that the rate of change in stroke volume variation (SVV) can be used to determine the volume of body fluids during major abdominal surgery. Anaesthesiologists can use SVV as a guide for the appropriate administration of intraoperative fluids to improve postoperative prognoses. Liver surgery is a major abdominal operation, and the amount of blood lost is typically higher than that during other general abdominal surgeries. Blood loss is positively correlated with the intraoperative fluid infusion volume, and greater blood loss is associated with more postoperative complications. Additionally, comorbid liver disease or cirrhosis can increase the complexity of liver tumour resection, causing difficulty in assessing intravascular volume and determining the appropriate intraoperative infusion volume.

Interventions

fluid will be guided by value of stroke volume variation

Sponsors

Kaohsiung Veterans General Hospital.
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

This trial had a randomised study design with simple randomisation and a fixed allocation ratio (1:1 to the low-SVV group or high-SVV group). The patients were blinded to the randomisation and allocation.

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* We initially selected 118 patients who required hepatectomy. * The physiological status of the patients was assessed in terms of American Society of Anesthesiologists scores I-III

Exclusion criteria

* Extreme body mass index (BMI) * Age under 20 or over 75 years * Emergency surgery * Preexisting cardiac, hepatic, renal, or coagulation disorder; hyperthyroidism; and sinus arrhythmia.

Design outcomes

Primary

MeasureTime frameDescription
The incidence of postoperative complications in the two groups.From day 1 to day 30 after surgery.calculate the incidence of postoperative complication within 30 days

Secondary

MeasureTime frameDescription
The differences of perioperative ALTExamination report on the 1st postoperative day.Calculate the difference of the perioperative physiological variables
The differences of perioperative eGFRExamination report on the 1st postoperative day.Calculate the difference of the perioperative physiological variables
The differences of perioperative creatinineExamination report on the 1st postoperative day.Calculate the difference of the perioperative physiological variables
The pain scaleup to three days postoperativelyAssessment of postoperative pain scale
The differences of perioperative HbExamination report on the 1st postoperative day.Calculate the difference of the perioperative physiological variables
The differences of perioperative arterial lactateExamination report on the 1st postoperative day.Calculate the difference of the perioperative physiological variables
The differences of perioperative albuminExamination report on the 1st postoperative day.Calculate the difference of the perioperative physiological variables
The differences of perioperative T.bilExamination report on the 1st postoperative day.Calculate the difference of the perioperative physiological variables

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026